Addex Therapeutics LtdAddex Therapeutics LtdAddex Therapeutics Ltd

Addex Therapeutics Ltd

No trades
No trades

Compare with Addex Therapeutics Ltd


Market capitalization
‪5.93 M‬USD
−9.31USD
‪−8.10 M‬USD
‪208.14 K‬USD
‪994.04 K‬
Beta (1Y)
0.84
Next report date
Report period
EPS estimate
Revenue estimate

Company info


CEO
Timothy Dyer
Headquarters
Geneva
Founded
2002
IPO date
May 22, 2007
ISIN
US00654J2069
CUSIP
00654J206
FIGI
BBG00R48ST95
Identifiers
ISIN US00654J2069
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.